These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 15681142

  • 1. Memory immune response generated in Cercopithecus aethiops against meningococcal polysaccharide serogroup C conjugate vaccine.
    Carmenate T, Guirola M, Alvarez A, Canaán L, González S, Caballero E, Menéndez T, Guillén G.
    FEMS Immunol Med Microbiol; 2005 Feb 01; 43(2):133-40. PubMed ID: 15681142
    [Abstract] [Full Text] [Related]

  • 2. Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates.
    Carmenate T, Canaán L, Alvarez A, Delgado M, González S, Menéndez T, Rodés L, Guillén G.
    FEMS Immunol Med Microbiol; 2004 Apr 09; 40(3):193-9. PubMed ID: 15039094
    [Abstract] [Full Text] [Related]

  • 3. Immunologic memory response induced by a meningococcal serogroup C conjugate vaccine using the P64k recombinant protein as carrier.
    Guirola M, Urquiza D, Alvarez A, Cannan-Haden L, Caballero E, Guillén G.
    FEMS Immunol Med Microbiol; 2006 Mar 09; 46(2):169-79. PubMed ID: 16487298
    [Abstract] [Full Text] [Related]

  • 4. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
    Cuello M, Cabrera O, Martinez I, Del Campo JM, Camaraza MA, Sotolongo F, Pérez O, Sierra G.
    Vaccine; 2007 Feb 26; 25(10):1798-805. PubMed ID: 17240485
    [Abstract] [Full Text] [Related]

  • 5. Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera.
    Guirola M, Carmenate T, Menéndez T, Alvarez A, González S, Guillén G.
    J Microbiol Methods; 2006 Apr 26; 65(1):135-43. PubMed ID: 16122825
    [Abstract] [Full Text] [Related]

  • 6. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G, Aase A, Caugant DA, Høiby EA, Fritzsønn E, Tangen T, Kristiansen P, Heggelund U, Rosenqvist E.
    Vaccine; 2005 May 31; 23(29):3762-74. PubMed ID: 15893613
    [Abstract] [Full Text] [Related]

  • 7. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.
    MacLennan J, Obaro S, Deeks J, Lake D, Elie C, Carlone G, Moxon ER, Greenwood B.
    J Infect Dis; 2001 Jan 01; 183(1):97-104. PubMed ID: 11087205
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant can improve protection induced by OMV vaccine against Neisseria meningitidis serogroups B/C in neonatal mice.
    Fukasawa LO, Dias WO, Schenkman RP, Raw I, Tanizaki MM.
    FEMS Immunol Med Microbiol; 2004 Jul 01; 41(3):205-10. PubMed ID: 15196569
    [Abstract] [Full Text] [Related]

  • 9. Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide.
    Menéndez T, Santiago-Vispo NF, Cruz-Leal Y, Coizeau E, Garay H, Reyes O, Batista Y, Cobas K, Carmenate T, Chinea G, Guillén G.
    Int J Med Microbiol; 2011 Jan 01; 301(1):16-25. PubMed ID: 20708963
    [Abstract] [Full Text] [Related]

  • 10. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
    Toropainen M, Saarinen L, Wedege E, Bolstad K, Mäkelä PH, Käyhty H.
    Vaccine; 2005 Sep 23; 23(40):4821-33. PubMed ID: 15970361
    [Abstract] [Full Text] [Related]

  • 11. Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies.
    Rosenqvist E, Høiby EA, Bjune G, Bryn K, Closs O, Feiring B, Klem A, Nøkleby H, Frølm LO.
    NIPH Ann; 1991 Dec 23; 14(2):169-79; discussion 180-1. PubMed ID: 1687481
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.
    Norheim G, Arne Høiby E, Caugant DA, Namork E, Tangen T, Fritzsønn E, Rosenqvist E.
    Vaccine; 2004 Jun 02; 22(17-18):2171-80. PubMed ID: 15149774
    [Abstract] [Full Text] [Related]

  • 13. Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?
    Tsai TF, Borrow R, Gnehm HE, Vaudaux B, Heininger U, Desgrandchamps D, Aebi C, Balmer P, Pedersen RD, Fritzell B, Siegrist CA.
    Clin Vaccine Immunol; 2006 Aug 02; 13(8):854-61. PubMed ID: 16893984
    [Abstract] [Full Text] [Related]

  • 14. Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine.
    El Bashir H, Heath PT, Papa T, Ruggeberg JU, Johnson N, Sinha R, Balfour G, Booy R.
    Vaccine; 2006 Mar 24; 24(14):2544-9. PubMed ID: 16417952
    [Abstract] [Full Text] [Related]

  • 15. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E, Høiby EA, Bjune G, Aase A, Halstensen A, Lehmann AK, Paulssen J, Holst J, Michaelsen TE, Nøkleby H, Frøholm LO, Closs O.
    Dev Biol Stand; 1998 Mar 24; 92():323-33. PubMed ID: 9554288
    [Abstract] [Full Text] [Related]

  • 16. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.
    Int J Infect Dis; 2008 May 24; 12(3):278-88. PubMed ID: 17981067
    [Abstract] [Full Text] [Related]

  • 17. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C.
    Prinz DM, Smithson SL, Westerink MA.
    J Immunol Methods; 2004 Feb 01; 285(1):1-14. PubMed ID: 14871530
    [Abstract] [Full Text] [Related]

  • 18. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
    Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ.
    Pediatr Infect Dis J; 2009 Mar 01; 28(3):186-93. PubMed ID: 19209097
    [Abstract] [Full Text] [Related]

  • 19. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine.
    Sakou II, Tzanakaki G, Tsolia MN, Sioumala M, Barbouni A, Kyprianou M, Papaevangelou V, Tsitsika A, Blackwell CC, Kafetzis D, Kremastinou J.
    Vaccine; 2009 Jul 16; 27(33):4408-11. PubMed ID: 19500554
    [Abstract] [Full Text] [Related]

  • 20. Safety and preliminary immunogenicity of MenC/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier.
    Pérez AE, Dickinson FO, Banderas F, Serrano T, Llanes R, Guzmán D, Díaz P, Alvarez A, Guirola M, Caballero E, Canaan-Haden L, Guillén G.
    FEMS Immunol Med Microbiol; 2006 Apr 16; 46(3):386-92. PubMed ID: 16553812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.